Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 3/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 4/20 | 0.42 |
| ▸ | PPARD | Q03181 | 4/20 | 0.42 |
| ▸ | PPARA | Q07869 | 4/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6397465 | 1.00 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL28036055 | 1.00 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL19471288 | 1.00 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5701162 | 1.00 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL10527741 | 0.98 | DGKA (0.48) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL158233 | 0.98 | DGKA (0.47) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL19583405 | 0.96 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL18204385 | 0.96 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5864687 | 0.94 | DGKA (0.42) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL19471289 | 0.93 | GPR84 (0.55) | LMNAPAMMAPTTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 631 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748367-A2 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2026-05-27 | — | — | EP | claimed |
| EP-4568640-B1 | SUNSCREEN COMPOSITION | DSM IP ASSETS BV (NL) | 2026-05-13 | — | — | EP | claimed |
| EP-4568640-A1 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2025-06-18 | — | — | EP | claimed |
| CN-119499108-A | Modified colorant, make-up-holding base product and preparation method thereof | 百特威(上海)化妆品有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119446702-A | To-be-cut piece of laminated inductor, preparation method of to-be-cut piece and single sintered body | 潮州三环（集团）股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2025032040-A1 | MULTI-LAYER FILTER MEDIUM | HENGST SE (DE) | 2025-02-13 | — | — | WO | claimed |
| WO-2024033221-A1 | SUNSCREEN COMPOSITION | DSM IP ASSETS B.V. (NL) | 2024-02-15 | — | — | WO | claimed |
| EP-3612182-B1 | RUPATADINE-CONTAINING PATCH | TEIKOKU SEIYAKU KK (JP) | 2024-01-10 | — | — | EP | claimed |
| CN-115957170-A | Foundation make-up liquid and preparation method thereof | 娇时日化（杭州）股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-112516022-B | Sun-screening lotion and preparation method thereof | 深圳市琉璃光生物科技有限公司 | 2022-08-12 | — | — | CN | claimed |
| EP-1536850-A1 | MEDICAL DEVICE HAVING HYDRATION INHIBITOR | Abbott Laboratories (US) | 2005-06-08 | — | — | EP | claimed |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | L'OREAL S.A. (FR) | 2004-11-25 | — | — | US | claimed |
| US-20040180039-A1 | Medical device having a hydration inhibitor | ABBOTT LABORATORIES | 2004-09-16 | — | — | US | claimed |
| WO-2004022124-A1 | MEDICAL DEVICE HAVING HYDRATION INHIBITOR | ABBOTT LABORATORIES (US) | 2004-03-18 | — | — | WO | claimed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | claimed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | claimed |
| EP-0620918-B1 | CARBON DIOXIDE DETECTOR | JOHNSON & JOHNSON PROFESSIONAL (GB) | 1997-07-30 | — | — | EP | claimed |
| US-5480611-A | Carbon dioxide detector | GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC. | 1996-01-02 | — | — | US | claimed |
| US-4725533-A | SILVER HALIDE LAYER AND TANNING DEVELOPER DISPERSED IN HIGH BOILING SOLVENT IN SEPARATE LAYER | FUJI PHOTO FILM CO., LTD. (JP) | 1988-02-16 | — | — | US | claimed |
| US-4693181-A | HOLLOW V-SHAPED GROOVE | ROYAL ORDNANCE PLC (GB) | 1987-09-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180039-A1 | Medical device having a hydration inhibitor | AQP1, WFS1, MME | DGKA 2547/4885LMNA 2861/4885PAM 473/4885 |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | CUTA, AUP1, PLIN3 | DGKA 413/4885LMNA 457/4885PAM 3531/4885 |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | DGKA 109/4885LMNA 3020/4885PAM 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.